Login / Signup

Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.

Morgan BirabaharanDavid C KaelberCharisse M OrmeTaraneh ParavarMaile Ann Young Karris
Published in: The British journal of dermatology (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • binding protein
  • respiratory syndrome coronavirus